Volume 5, Supplement 3SupplementDocetaxel and Thalidomide as a Treatment Option for Androgen-Independent, Nonmetastatic Prostate CancerWilliam L DahutJames L GulleyPhilip M ArlenWilliam D FiggGregory D LeonardDocetaxelAndrogen-independent prostate cancerThalidomidePalliative